日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT

完善辅助性 CDK4/6 抑制剂的风险评估，超越临床试验纳入标准：根据 ADAPT 整合复发评分和内分泌反应性

期刊:Breast Care
影响因子:2.1
doi:10.1159/000550825
Braun, Michael; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Luedtke-Heckenkamp, Kerstin; Darsow, Maren; Forstbauer, Helmut; Polata, Silke; Grischke, Eva-Maria; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Zu Eulenburg, Christine; Kates, Ronald; Burmeister, Sandy; Graeser, Monika; Wuerstlein, Rachel; Baehner, Rick; Christgen, Matthias; Kreipe, Hans Heinrich; Harbeck, Nadia
CDK4
ADA
发表日期：2026
文献求助 收藏

Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

在WSG-ADAPT-TN试验中，免疫调节基因网络可预测三阴性乳腺癌患者对降阶梯、不含蒽环类药物的新辅助化疗的治疗反应和生存期。

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02275-0
Korbie, Darren; Stirzaker, Clare; Gluz, Oleg; Zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J; Trau, Matt; Graeser, Monika; Harbeck, Nadia
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
ADA
发表日期：2025
文献求助 收藏

Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

三阴性乳腺癌患者的基因改变、治疗反应和生存率：一项随机临床试验的二次分析

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2024.61639
Richters, Lisa; Gluz, Oleg; Weber-Lassalle, Nana; Christgen, Matthias; Haverkamp, Heinz; Kuemmel, Sherko; Kayali, Mohamad; Kates, Ronald E; Grischke, Eva-Maria; Altmüller, Janine; Forstbauer, Helmut; Thiele, Holger; Braun, Michael; Warm, Mathias; Ossowski, Anna; Wuerstlein, Rachel; Ernst, Corinna; Graeser, Monika; Linn, Sabine C; Nitz, Ulrike; Hauke, Jan; Kreipe, Hans Heinrich; Schmutzler, Rita K; Hahnen, Eric; Harbeck, Nadia
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN

HER2低表达状态作为一种独特的乳腺癌亚型：是谬论还是事实？对WSG试验WSG-ADAPT-HR+/HER2-、WSG-PlanB和WSG-ADAPT-TN的分析

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-01969-z
Schmidt, Gilda; Gluz, Oleg; Christgen, Matthias; Reinisch, Mattea; Kümmel, Sherko; Nitz, Ulrike; Braun, Michael; Aktas, Bahriye; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Mahlberg, Rolf; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Stefek, Andrea; Wuerstlein, Rachel; Graeser, Monika; Jóźwiak, Katarzyna; Burmeister, Sandy; Zu Eulenburg, Christine; Lauseker, Michael; Kolberg-Liedtke, Cornelia; Prat, Aleix; Schmid, Peter; Baehner, Rick; Kreipe, Hans Heinrich; Solomayer, Erich-Franz; Harbeck, Nadia
肿瘤
HER2
肿瘤免疫
乳腺癌
ADA
发表日期：2025
文献求助 收藏

GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer

GAIN2试验：早期乳腺癌强化化疗与个体化剂量密集化疗的总生存期比较

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-024-00675-x
Möbus, Volker; Lück, Hans-Joachim; Ladda, Ekkehart; Klare, Peter; Engels, Knut; Schmidt, Marcus; Schneeweiss, Andreas; Grischke, Eva-Maria; Wachsmann, Grischa; Forstbauer, Helmut; Untch, Michael; Marmé, Frederik; Blohmer, Jens-Uwe; Jackisch, Christian; Huober, Jens; Stickeler, Elmar; Reinisch, Mattea; Link, Theresa; Sinn, Bruno; Janni, Wolfgang; Denkert, Carsten; Seiler, Sabine; Solbach, Christine; Schmatloch, Sabine; Rey, Julia; Loibl, Sibylle
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial

FOLFOX/贝伐珠单抗+/-伊立替康一线治疗转移性结直肠癌的疗效和生活质量——AIO CHARTA试验的最终结果

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-023-02496-4
Schmoll, Hans-Joachim; Mann, Julia; Meinert, Fabian; Garlipp, Benjamin; Borchert, Kersten; Vogel, Arndt; Goekkurt, Eray; Kaiser, Ulrich; Hoeffkes, Heinz-Gert; Rüssel, Jörn; Kanzler, Stephan; Edelmann, Thomas; Forstbauer, Helmut; Göhler, Thomas; Hannig, Carla; Hildebrandt, Bert; Roll, Carsten; Bokemeyer, Carsten; Steighardt, Jörg; Cygon, Franziska; Ibach, Stefan; Stein, Alexander; Tintelnot, Joseph
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial

RNA 特征对接受 12 周新辅助帕妥珠单抗联合曲妥珠单抗（含或不含紫杉醇）治疗后 pCR 和生存率的影响（WSG-ADAPT HER2+/HR- 试验）

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-1587
Graeser, Monika; Gluz, Oleg; Biehl, Claudia; Ulbrich-Gebauer, Daniel; Christgen, Matthias; Palatty, Jenci; Kuemmel, Sherko; Grischke, Eva-Maria; Augustin, Doris; Braun, Michael; Potenberg, Jochem; Wuerstlein, Rachel; Krauss, Katja; Schumacher, Claudia; Forstbauer, Helmut; Reimer, Toralf; Stefek, Andrea; Fischer, Hans Holger; Pelz, Enrico; Zu Eulenburg, Christine; Kates, Ronald; Ni, Hua; Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Kreipe, Hans Heinrich; Nitz, Ulrike; Harbeck, Nadia
HER2
ADA
发表日期：2023
文献求助 收藏

Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis

脑转移瘤术中放疗疗效评估：一项前瞻性观察研究及配对比较分析的结果

期刊:Journal of Neuro-Oncology
影响因子:3.1
doi:10.1007/s11060-023-04380-w
Layer, Julian P; Hamed, Motaz; Potthoff, Anna-Laura; Dejonckheere, Cas S; Layer, Katharina; Sarria, Gustavo R; Scafa, Davide; Koch, David; Köksal, Mümtaz; Kugel, Fabian; Grimmer, Molina; Holz, Jasmin A; Zeyen, Thomas; Friker, Lea L; Borger, Valeri; Schmeel, F Carsten; Weller, Johannes; Hölzel, Michael; Schäfer, Niklas; Garbe, Stephan; Forstbauer, Helmut; Giordano, Frank A; Herrlinger, Ulrich; Vatter, Hartmut; Schneider, Matthias; Schmeel, L Christopher
神经科学
发表日期：2023
文献求助 收藏

Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes

脑转移瘤术中或术后立体定向放射治疗：开始全身治疗的时间及其他与患者相关的结局

期刊:Journal of Neuro-Oncology
影响因子:3.1
doi:10.1007/s11060-023-04464-7
Dejonckheere, Cas S; Layer, Julian P; Hamed, Motaz; Layer, Katharina; Glasmacher, Andrea; Friker, Lea L; Potthoff, Anna-Laura; Zeyen, Thomas; Scafa, Davide; Koch, David; Garbe, Stephan; Holz, Jasmin A; Kugel, Fabian; Grimmer, Molina; Schmeel, Frederic Carsten; Gielen, Gerrit H; Forstbauer, Helmut; Vatter, Hartmut; Herrlinger, Ulrich; Giordano, Frank A; Schneider, Matthias; Schmeel, Leonard Christopher; Sarria, Gustavo R
神经科学
发表日期：2023
文献求助 收藏

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

WSG-ADAPT TN试验中基质肿瘤浸润淋巴细胞（sTILs）对三阴性早期乳腺癌新辅助化疗疗效的影响

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-022-01552-w
Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Garke, Madlen; Christgen, Matthias; Kates, Ronald; Grischke, Eva Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Wuerstlein, Rachel; Graeser, Monika; Nitz, Ulrike; Kreipe, Hans; Gluz, Oleg; Harbeck, Nadia
肿瘤
肿瘤免疫
乳腺癌
细胞生物学
ADA
发表日期：2022
文献求助 收藏